Centennial Hill Day Participants Urge Congress to Support NIH, Medicare Coverage of Continuous Glucose Monitors
Endocrine Society members representing the Society’s leadership, APOCC, CACC, RACC, Centennial Task Force and Future Leaders to Advance Research in Endocrinology (FLARE) headed to Capitol Hill April 28 to educate Members of Congress about the importance of the endocrinology field. The Society held the Hill Day and a Congressional reception as part of its Centennial celebration.
Participants visited with almost 60 congressional offices. At the end of the day, the Society hosted a Congressional Reception on Capitol Hill to celebrate our 100th birthday. We were honored to have the co-chairs of the Congressional Diabetes Caucus, Representatives Diana DeGette (D-CO) and Tom Reed (R-NY), join us and speak about their families’ experiences with diabetes and their appreciation to the Society for the work we do, including our robust advocacy on the Hill for diabetes legislation and research funding.
Take Action: You can lend your voice to the Society’s advocacy efforts concerning NIH funding and Medicare coverage of CGM. To take action, visit our online advocacy center to send a message to your Representative and Senators. It only takes a moment and will have significant impact.
Endocrine Society Continues to Advocate for Establishing Criteria to Identify EDCs in the European Union; New Scientific Publication Supports Society’s Position on EDC Roadmap
On Monday, April 25, a new scientific article authored by several Endocrine Society members was published in the journal Environmental Health Perspectives. The article, “Scientific Issues Relevant to Setting Regulatory Criteria to Identify Endocrine Disrupting Substances in the European Union,” provides further support for the Society’s position that the best option for criteria to identify EDCs should be based on the widely-accepted World Health Organization / International Program on Chemical Safety (WHO/IPCS) definition.
The European Commission is currently carrying out an impact assessment to compare four different options for defining criteria for the identification of endocrine disruptors. The assessment and development of criteria for EDC identification is managed by the Directorate-General for Health and Food Safety, led by Commissioner Vytenis Andriukaitis, MD. The Endocrine Society has consistently argued that the current regulatory apparatus is insufficient for the protection of human health from harms due to EDC exposures, and the Society has advocated that Option 3 is the most appropriate approach for establishing criteria to define EDCs because it includes multi-level categorization based on level of evidence and does not include potency as a criterion. This option is similar to the existing framework for identifying and regulating carcinogens.
The Endocrine Society has been highly engaged in the process for establishing criteria to identify EDCs in the European Union. On February 29, members of the Endocrine Society met with policymakers in the EU, including Commissioner Andriukaitis, to provide scientific expertise, comments, and concerns regarding the Commission’s process. The Society will continue to engage with policymakers worldwide to ensure that regulatory decisions regarding EDCs are based on the latest endocrine science. For more information on the Society positions on EDCs in the EU, please see our position statement on the Society’s advocacy website.
The Centers for Medicare and Medicaid Services (CMS) has released 2015 mid-year Quality and Resource Use Reports (QRURs) to groups and solo practitioners. The QRURs were made available to provide eligible professionals and groups with interim information on their performance on a subset of the measures used to calculate the 2017 Value Modifier. The information contained in the QRURs is based on care provided from July 1, 2014 to June 30, 2015. More information on the mid-year QRURs can be found on the 2015 QRUR and 2017 Value Modifier page, and the reports can be accessed on the CMS Enterprise Portal.
Submit your Research Ideas to Cancer Moonshot Panel
To support involvement from all stakeholders in the cancer research community, the National Cancer Institute (NCI) has opened a new online platform for the submission of input on potential National Cancer Moonshot efforts. As reported previously in Endocrine News, President Obama’s January 12 State of the Union address included a call for a concerted research effort towards a cure for cancer. The new effort, dubbed the “Cancer Moonshot” is led by Vice-President Joe Biden and aims to improve the availability of new therapies for patients while also improving the detection and prevention of cancer.
NCI is accepting ideas in the following areas:
Cancer clinical trials
Dissemination and population sciences
Immunotherapy, combination therapy, and immunoprevention
Tumor evolution and progression
Other exceptional opportunities
Ideas will be considered by a Blue Ribbon Panel, established to assist the National Cancer Advisory Board in providing advice and guidance to the Cancer Moonshot Initiative.
Take Action: To submit your research ideas for consideration, please register at the cancer research ideas website. Please note that ideas are requested by July 1, 2016.
NICHD Encourages Researchers to Contribute to New Online Data-Sharing Resource
Recently, the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) launched a new centralized resource, the NICHD Data and Specimen Hub (DASH). Consistent with NIH Policies on data sharing, DASH will enable researchers to store and access de-identified data from NICHD-funded research studies for use in secondary research. There is no cost to use DASH; however, users must register on the DASH website and create an account. Requests for data will be reviewed by NICHD to “confirm that the proposed use is scientifically and ethically appropriate and is permitted by the institutions that submitted the data.”
For more information on DASH, and instructions for requesting and submitting data, please see the DASH website at https://dash.nichd.nih.gov/.